Rapid identity and quantity CQA test for multivalent mRNA drug product formulations
RY Gao, CM Riley, E Toth, RH Blair, MN Gerold… - Vaccines, 2022 - mdpi.com
The COVID-19 pandemic highlighted mRNA as a promising platform for vaccines and
therapeutics. Many of the analytical tools used to characterize the critical quality attributes of …
therapeutics. Many of the analytical tools used to characterize the critical quality attributes of …
An evaluation of the InDevR FluChip-8G insight microarray assay in characterizing influenza a viruses
Influenza viruses are an important cause of disease in both humans and animals, and their
detection and characterization can take weeks. In this study, we sought to compare classical …
detection and characterization can take weeks. In this study, we sought to compare classical …
[HTML][HTML] RISK OF SWINE INFLUENZA FOR VETERINARY MEDICINE AND HUMAN HEALTH IN UKRAINE
BT Stegniy, OM Rula, NM Muzyka, K Dunaiev Yu… - RISK, 2023 - jvmbbs.kharkov.ua
The article provides a brief review of the literature on influenza viruses, including their
prevalence, classification, pathogenicity, ability to mutate and reassort, and some …
prevalence, classification, pathogenicity, ability to mutate and reassort, and some …
[HTML][HTML] A multi-country field validation of the FluChip-8G Insight Assay
JM Velasco, S Shrestha, MT Valderama… - Journal of Virological …, 2021 - Elsevier
Introduction It is critical to rapidly detect novel and non-seasonal influenza strains. Currently
available assays have limited sensitivity in detecting novel influenza subtypes. We …
available assays have limited sensitivity in detecting novel influenza subtypes. We …